US Patent 7972603 Stable immunogenic product comprising antigenic heterocomplexes
Patent 7972603 was granted and assigned to Neovacs on July, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+492 characters)
Article
Patent abstract
The invention relates to a stable immunogenic product for the induction of antibodies against one or more antigenic proteins in a subject. The invention is characterised in that it comprises proteinaceous immunogenic heterocomplexes which are formed by associations between (i) antigenic protein molecules and (ii) proteinaceous carrier molecules and in that less than 40% of the antigenic proteins (i) are linked to the proteinaceous carrier molecules (ii) by a covalent bond.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Daniel Zagury0
Helene Le Buannec0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07972603 Stable immunogenic product comprising antigenic heterocomplexes US Patent 7972603 Stable immunogenic product comprising antigenic heterocomplexes
Infobox
Patent Number
07972603
Patent Number
7972603
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07972603 Stable immunogenic product comprising antigenic heterocomplexes
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07972603
Date of patent
July 5, 2011
Patent application number
10527975
Date Filed
September 16, 2003
Patent primary examiner
Find more entities like US Patent 7972603 Stable immunogenic product comprising antigenic heterocomplexes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.